Correlation Between Surrozen Warrant and EFFECTOR Therapeutics
Can any of the company-specific risk be diversified away by investing in both Surrozen Warrant and EFFECTOR Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Surrozen Warrant and EFFECTOR Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Surrozen Warrant and EFFECTOR Therapeutics, you can compare the effects of market volatilities on Surrozen Warrant and EFFECTOR Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Surrozen Warrant with a short position of EFFECTOR Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Surrozen Warrant and EFFECTOR Therapeutics.
Diversification Opportunities for Surrozen Warrant and EFFECTOR Therapeutics
0.42 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Surrozen and EFFECTOR is 0.42. Overlapping area represents the amount of risk that can be diversified away by holding Surrozen Warrant and EFFECTOR Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on EFFECTOR Therapeutics and Surrozen Warrant is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Surrozen Warrant are associated (or correlated) with EFFECTOR Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of EFFECTOR Therapeutics has no effect on the direction of Surrozen Warrant i.e., Surrozen Warrant and EFFECTOR Therapeutics go up and down completely randomly.
Pair Corralation between Surrozen Warrant and EFFECTOR Therapeutics
Assuming the 90 days horizon Surrozen Warrant is expected to generate 6.47 times more return on investment than EFFECTOR Therapeutics. However, Surrozen Warrant is 6.47 times more volatile than EFFECTOR Therapeutics. It trades about 0.22 of its potential returns per unit of risk. EFFECTOR Therapeutics is currently generating about 0.01 per unit of risk. If you would invest 4.78 in Surrozen Warrant on September 1, 2024 and sell it today you would lose (2.81) from holding Surrozen Warrant or give up 58.79% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 68.57% |
| Values | Daily Returns |
Surrozen Warrant vs. EFFECTOR Therapeutics
Performance |
| Timeline |
| Surrozen Warrant |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Good
| EFFECTOR Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Surrozen Warrant and EFFECTOR Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Surrozen Warrant and EFFECTOR Therapeutics
The main advantage of trading using opposite Surrozen Warrant and EFFECTOR Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Surrozen Warrant position performs unexpectedly, EFFECTOR Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in EFFECTOR Therapeutics will offset losses from the drop in EFFECTOR Therapeutics' long position.| Surrozen Warrant vs. Surrozen | Surrozen Warrant vs. Celularity | Surrozen Warrant vs. Quantum Si incorporated | Surrozen Warrant vs. Humacyte |
| EFFECTOR Therapeutics vs. Celularity | EFFECTOR Therapeutics vs. Humacyte | EFFECTOR Therapeutics vs. NRx Pharmaceuticals | EFFECTOR Therapeutics vs. Reviva Pharmaceuticals Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Other Complementary Tools
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities |